{"The": [0], "recent": [1], "emergence": [2], "of": [3, 34, 38, 93, 139], "a": [4, 52, 91], "novel": [5], "coronavirus": [6], "(SARS-CoV-2)": [7], "in": [8, 44, 74, 118], "China": [9], "has": [10], "caused": [11], "significant": [12], "public": [13], "health": [14], "concerns.": [15], "Recently,": [16], "ACE2": [17, 48], "was": [18], "reported": [19], "as": [20], "an": [21], "entry": [22], "receptor": [23, 86], "for": [24, 60, 85], "SARS-CoV-2.": [25, 123], "In": [26], "this": [27], "study,": [28], "we": [29], "present": [30], "the": [31, 35, 66, 78, 111, 129, 143], "crystal": [32], "structure": [33], "C-terminal": [36], "domain": [37, 104], "SARS-CoV-2": [39, 112], "(SARS-CoV-2-CTD)": [40], "spike": [41], "(S)": [42], "protein": [43], "complex": [45], "with": [46, 110], "human": [47], "(hACE2),": [49], "which": [50], "reveals": [51], "hACE2-binding": [53], "mode": [54], "similar": [55], "overall": [56], "to": [57, 82, 108], "that": [58, 70], "observed": [59], "SARS-CoV.": [61], "However,": [62], "atomic": [63], "details": [64], "at": [65], "binding": [67, 87], "interface": [68], "demonstrate": [69], "key": [71], "residue": [72], "substitutions": [73], "SARS-CoV-2-CTD": [75], "slightly": [76], "strengthen": [77], "interaction": [79], "and": [80, 98, 122, 132], "lead": [81], "higher": [83], "affinity": [84], "than": [88], "SARS-RBD.": [89], "Additionally,": [90], "panel": [92], "murine": [94], "monoclonal": [95], "antibodies": [96, 100], "(mAbs)": [97], "polyclonal": [99], "(pAbs)": [101], "against": [102, 142], "SARS-CoV-S1/receptor-binding": [103], "(RBD)": [105], "were": [106], "unable": [107], "interact": [109], "S": [113], "protein,": [114], "indicating": [115], "notable": [116], "differences": [117], "antigenicity": [119], "between": [120], "SARS-CoV": [121], "These": [124], "findings": [125], "shed": [126], "light": [127], "on": [128], "viral": [130], "pathogenesis": [131], "provide": [133], "important": [134], "structural": [135], "information": [136], "regarding": [137], "development": [138], "therapeutic": [140], "countermeasures": [141], "emerging": [144], "virus.": [145]}